Trained immunity provides a unifying framework linking innate immune memory to both protective and maladaptive inflammation ...

Eleven patients with refractory autoimmune hemolytic anemia (AIHA) were all brought into drug-free remission with CAR T-cell ...

Hutchmed has continued to test sovleplenib in wAIHA in parallel, culminating in the delivery of data from a Chinese phase 3 ...

CRISPR Therapeutics (NASDAQ:CRSP) is one of the best emerging technology stocks to invest in. On December 22, CRISPR Therapeutics released a comprehensive clinical update on zugocaptagene geleucel ...

ZUG, Switzerland and BOSTON - CRISPR Therapeutics (NASDAQ:CRSP) reported Monday that its investigational CD19-targeting allogeneic CAR T therapy, zugocaptagene geleucel (zugo-cel), has demonstrated ...

Although the exact incidence of IMHA in dogs is unknown, it’s considered one of the most common autoimmune conditions faced by our canine companions. Because the condition is potentially deadly, pet ...

Atypical hemolytic uremic syndrome (aHUS) is a rare cause of thrombotic microangiopathy (TMA) caused by the dysregulation of the alternative complement pathway. The diagnosis of TMA is made clinically ...

Her treatment plan, including transfusions and medication, has been successful and she has returned to school. Her treatment included blood transfusions, infusions of a mild chemotherapy drug and ...

Courtesy Getty Images Learn more about the similarities and differences between alloimmunization in HDFN and autoimmune hemolytic disease. If you or your loved one has been diagnosed with hemolytic ...

Pregnancy-related warm autoantibodies, which some have said may be connected to hemolytic disease of the fetus and newborn (HDFN), appeared not to harm mothers or babies, according to a new study ...

While Sanofi originally had its eye on tolebrutinib when it purchased its partner Principia Biopharma for $3.7 billion five years ago, another one of the Bruton tyrosine kinase (BTK) inhibitors ...